F/m Investments LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1834499 WASHINGTON, DC

Position in REGN

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$13,431,573

-$4,177,097 QoQ

Shares Held

17,384

-23.8% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

1.22%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

F/m Investments LLC holds $71,155,293 across 22 Biotechnology names. REGN ranks #1 (18.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc. This page	17,384	$13,431,573
2	COGT	Cogent Biosciences, Inc.	226,142	$8,704,205
3	SYRE	Spyre Therapeutics, Inc.	99,460	$5,016,762
4	TVTX	Travere Therapeutics, Inc.	164,990	$4,901,852
5	MIRM	Mirum Pharmaceuticals, Inc.	50,911	$4,703,158
6	KALV	KalVista Pharmaceuticals, Inc.	226,991	$4,569,328
7	NKTR	Nektar Therapeutics	61,104	$4,396,432
8	BBIO	BridgeBio Pharma, Inc.	54,599	$4,054,521

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$13,431,573	17,384	-23.8%	Shares	Sole	2026-05-11
2025-12-31	$17,608,670	22,813	+248.7%	Shares	Sole	2026-02-03
2025-09-30	$3,678,932	6,543	-2.2%	Shares	Sole	2025-11-13
2025-06-30	$3,511,200	6,688	+1.3%	Shares	Sole	2025-08-13
2025-03-31	$4,185,283	6,599	-5.8%	Shares	Sole	2025-05-14
2024-12-31	$4,988,446	7,003	+8.5%	Shares	Sole	2025-02-13
2024-09-30	$6,783,651	6,453	-3.8%	Shares	Sole	2024-10-29
2024-06-30	$7,050,309	6,708	+47.9%	Shares	Sole	2024-07-29
2022-06-30	$2,681,956	4,537	-0.3%	Shares	Sole	2022-08-04
2021-09-30	$2,752,963	4,549	+0.3%	Shares	Sole	2021-11-01
2021-06-30	$2,534,095	4,537	—	Shares	Sole	2021-08-10
No filing history on record for this holder in this stock.